Search
for
Sort by
Research 421–450 of 1000+
- Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex
- Medulla loss of scalp hair in breast cancer patients determined by near-infrared microscopy
- Novel electroporation-based treatments for breast cancer
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Scalp Cooling for Chemotherapy-Induced Alopecia in Breast Cancer: A Recent Literature Review
- Symptom Clusters in Brazilian Women With Stage I and Stage III Nonmetastatic Breast Cancer: A Cross‐Sectional Study
- Environmental factors influencing hormone receptor positive breast cancer incidence: integrating chemical signatures from dust wipes with self-reported sources of exposure
- The Role of Herbal Medicine in Breast Cancer Treatment: Evidence for Therapeutic Effectiveness
- Symptom Experience and Coping Strategies Among Patients with Breast Cancer Receiving Chemotherapy
- QS8: Analysis of the Whole Transcriptome in Breast Cancer Patients Undergoing Radiotherapy and Breast Reconstruction
- Evaluation of the Hemogram of Breast Cancer Patients Treated by Therapeutic Protocol Based on Immunohistochemical Analysis: A Retrospective Study
- Spironolactone use and the risk of breast cancer
- Abstract P5-21-05: ERALOP study: Post adjuvant FEC - docetaxel chemotherapy for early breast cancer: Hair regrowth in the real life
- An Approach to Identify Targets of Breast Cancer Stem Cells
- [A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine].
- Survival of Lymph Node-Negative Breast Cancer Patients in Relation to Number of Lymph Nodes Examined
- 61537 No Increased Risk of Breast or Gynecologic Cancers in Women with 5α-Reductase Inhibitor Exposure for Female Pattern Hair Loss: A Population-Based Propensity Score-Matched Cohort Study
- Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer
- Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy
- A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer
- Predisposing and Overall Effects of Reproductive Hormones on Breast Cancer: A Review
- Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
- Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone
- A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
- Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- Hair keratin KRT81 is expressed in normal and breast cancer cells and contributes to their invasiveness
- Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis